ReviewPediatric research2026
Polycyclic aromatic hydrocarbons and perinatal outcomes: a scoping review.
Review in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are generated during the incomplete combustion of carbon-based materials and have been identified as mutagenic, teratogenic, carcinogenic, and immunotoxic agents. Maternal exposure to PAHs via inhalation, occupational exposures, dietary intake, or dermal absorption has been linked to an elevated risk of infertility, spontaneous abortion and preterm birth. PAHs can cross the placenta, potentially leading to adverse fetal outcomes including growth restriction and congenital anomalies. Additionally, both prenatal and postnatal exposure to PAHs have been associated with a range of childhood disorders, including asthma, attention deficit hyperactivity disorder, autism spectrum disorders, pediatric cancers, and allergic conditions. The objective of this scoping review is to provide a comprehensive overview of current evidence regarding the effects of PAH exposure on maternal, fetal, neonatal, and childhood health outcomes. IMPACT: Polycyclic aromatic hydrocarbons (PAHs) are hazardous organic pollutants that have been implicated in adverse maternal, fetal, neonatal and childhood outcomes. Appreciation of the mechanisms, exposure pathways, and their correlation with health outcomes can facilitate the development of informed policies and effective strategies for exposure management, prevention and/or treatment of diseases associated with PAH exposure. This scoping review summarizes current literature on the impact of PAH exposure on perinatal and childhood health outcomes.
Identifiers
42399685What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.